Interpace Biosciences®, Inc. Annual report pursuant to Section 13 and 15(d)

Schedule of Fair Value, Assets Measured On Recurring Basis, Unobservable Input Reconciliation (Details)

v3.24.1

Schedule of Fair Value, Assets Measured On Recurring Basis, Unobservable Input Reconciliation (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Beginning balance	$ 12,253
Payments	(2,500)
Transferred to accrued expenses	(754)
Accretion/interest accrued	112
Adjustment to fair value/mark to market	685
Ending balance	9,796
BroadOak Loan [Member]
Beginning balance	11,165
Payments	(2,500)
Transferred to accrued expenses
Accretion/interest accrued
Adjustment to fair value/mark to market	678
Ending balance	9,343
Asuragen [Member]
Beginning balance	1,088
Payments
Transferred to accrued expenses	(754)
Accretion/interest accrued	112
Adjustment to fair value/mark to market	7
Ending balance	$ 453

- Definition

Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Accretion.

+ References

No definition available.

+ Details

Name:	IDXG_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAccretion
Namespace Prefix:	IDXG_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-SubTopic 10
-Topic 820
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.

+ References

No definition available.

+ Details

Name:	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.

+ References

+ Details

Name:	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_BalanceSheetLocationAxis=IDXG_BroadOakLoanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=IDXG_AsuragenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: